AIIMS probe puts Indian trials boom in uncertain light
The integrity and morality of India’s clinical trials boom are under question following revelations about the deaths of babies during studies at a prestigious public hospital and medical school in New Dehli.
Clinical trials warm to oncology, cool on cardiology
Increasing interest in cancer therapies and a marked decline in the number of cardiology studies were among the salient trends in the disease focus of clinical trials worldwide over the last few years, a new analysis indicates.
More Nasdaq pressure on troubled Datatrak
Datatrak, the US-based eClinical specialist currently considering its future amid mounting financial losses, has received further warnings from Nasdaq about the company’s continuing eligibility for listing on the US exchange.
|
 |
US NME applications show encouraging trend
Marketing applications for new molecular entities (NMEs) in the US rose by 33% from 21 to 28 between 2006 and 2007, suggesting that the biopharmaceutical industry may be recovering from its much-discussed productivity drought.
AmeriStart tie-up to raise Factory CRO profile in North America
Factory CRO, which specialises in medical device studies for European and US regulatory approvals, has tied up with business development company AmeriStart to promote the CRO’s services in North America.
Asia the winner, W Europe the loser as oncology trials head east
Western Europe’s loss is Asia’s gain as pharmaceutical and biotechnology companies looking to cut costs and accelerate recruitment shift oncology clinical trials eastward, a recent analysis found.
|